BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu M, Xue W, Ma Z, Bai J, Wu S. Resveratrol Reduces the Incidence of Portal Vein System Thrombosis after Splenectomy in a Rat Fibrosis Model. Oxid Med Cell Longev 2016;2016:7453849. [PMID: 27433290 DOI: 10.1155/2016/7453849] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Han JB, Shu QH, Zhang YF, Yi YX. Predictive Value of Inflammation Biomarkers in Patients with Portal Vein Thrombosis. J Clin Transl Hepatol 2021;9:384-91. [PMID: 34221924 DOI: 10.14218/JCTH.2020.00159] [Reference Citation Analysis]
2 Ma Z, Zhang Y, Li Q, Xu M, Bai J, Wu S. Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production. PLoS One 2017;12:e0183426. [PMID: 28817659 DOI: 10.1371/journal.pone.0183426] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
3 Izzo C, Annunziata M, Melara G, Sciorio R, Dallio M, Masarone M, Federico A, Persico M. The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials. Nutrients 2021;13:933. [PMID: 33805795 DOI: 10.3390/nu13030933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 El-Sheikh AA, Morsy MA, Okasha AM. Inhibition of NF-κB/TNF-α pathway may be involved in the protective effect of resveratrol against cyclophosphamide-induced multi-organ toxicity. Immunopharmacol Immunotoxicol 2017;39:180-7. [PMID: 28463035 DOI: 10.1080/08923973.2017.1318913] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
5 Song J, Huang Y, Zheng W, Yan J, Cheng M, Zhao R, Chen L, Hu C, Jia W. Resveratrol reduces intracellular reactive oxygen species levels by inducing autophagy through the AMPK-mTOR pathway. Front Med 2018;12:697-706. [PMID: 30421395 DOI: 10.1007/s11684-018-0655-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
6 Bredthauer A, Kopfmueller M, Gruber M, Pfaehler SM, Lehle K, Petermichl W, Seyfried T, Bitzinger D, Redel A. Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy? Cardiovasc Ther 2020;2020:9783630. [PMID: 32405324 DOI: 10.1155/2020/9783630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Jia X, Zhang R, Guo J, Yue H, Liu Q, Guo L, Zhang Q. Resveratrol Supplementation Prevents Hypertension in Hypertensive Pregnant Rats by Increasing Sodium Excretion and Serum Nitric Oxide Level. Int J Hypertens 2020;2020:4154010. [PMID: 32099672 DOI: 10.1155/2020/4154010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Giordo R, Zinellu A, Eid AH, Pintus G. Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders. Molecules 2021;26:856. [PMID: 33562030 DOI: 10.3390/molecules26040856] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]